Phase I/II storm study: Intravenous delivery of a novel oncolytic immunotherapy agent, Coxsackievirus A21, in advanced cancer patients

समान संसाधन

• Oncolytic immunotherapy for the treatment of non-muscle invasive bladder cancer using intravesical coxsackievirus A21
  द्वारा: Annels, Nicola E, और अन्य
  प्रकाशित: (2015)
• Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 Virus
  द्वारा: Annels, Nicola E., और अन्य
  प्रकाशित: (2018)
• Applications of coxsackievirus A21 in oncology
  द्वारा: Bradley, Stephen, और अन्य
  प्रकाशित: (2014)
• Plasmacytoid dendritic cells orchestrate innate and adaptive anti-tumor immunity induced by oncolytic coxsackievirus A21
  द्वारा: Müller, Louise M. E., और अन्य
  प्रकाशित: (2019)
• Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances
  द्वारा: Simpson, Guy R, और अन्य
  प्रकाशित: (2016)